GAF Asbestos Trust Fund
Asbestos liabilities historically associated with GAF Corporation are handled through the G-I Holdings, Inc. Asbestos Personal Injury Settlement Trust. G-I Holdings is the successor to GAF Corporation by merger. This page uses the official G-I Trust Distribution Procedures, official payment notices, filing instructions, federal court records and SEC filings to explain claim values, exposure requirements and the payment rate supported by current trust materials.
GAF and G-I Holdings Trust Facts
| Historical company | GAF Corporation |
|---|---|
| Successor debtor | G-I Holdings, Inc., successor to GAF Corporation by merger |
| Chapter 11 filing | G-I Holdings filed for Chapter 11 protection in January 2001 |
| Trust | G-I Holdings, Inc. Asbestos Personal Injury Settlement Trust |
| Reorganization/trust structure | Section 524(g) asbestos trust established under the confirmed G-I reorganization plan |
| Payment rate supported by official trust notice | 5% for claims first eligible for payment after November 22, 2022 while the proposed decrease was being resolved |
| Mesothelioma scheduled value | $155,000 |
| Mesothelioma average value | $225,000 |
| Mesothelioma maximum Individual Review value | $450,000 |
| Lung Cancer 1 scheduled value | $45,000 |
Payment-rate note: An official December 1, 2022 notice states that claims first eligible for payment after November 22, 2022 would be paid at 5% while the Trustees’ proposed decrease was being resolved. The current official resource page continues to publish that notice and does not surface a newer payment-percentage notice in the materials reviewed for this update.
GAF and G-I Holdings Bankruptcy History
SEC filings identify G-I Holdings as the successor to GAF Corporation by merger and state that G-I Holdings entered Chapter 11 proceedings because of asbestos-related bodily-injury claims. The confirmed reorganization created a Section 524(g) asbestos trust to process and pay covered asbestos personal-injury claims.
The trust should therefore be identified accurately as the G-I Holdings, Inc. Asbestos Personal Injury Settlement Trust, even when readers search for it as the “GAF asbestos trust.” The historical GAF name explains the exposure connection; G-I Holdings is the debtor and trust name used in the governing documents.
Trust Funding Under the Reorganization Plan
The federal confirmation record states that, on the effective date, the plan sponsor would contribute $215 million in cash to partially fund the asbestos trust and Reorganized G-I would issue a 10-year $560 million Trust Note. The note was structured to provide interest and principal payments to support payment of asbestos claims.
These figures describe historical plan funding commitments. They are not the trust’s current asset balance and should not be added together and presented as cash currently available to claimants.
Disease Scheduled and Maximum Values
The official Second Amended G-I Trust Distribution Procedures list the following scheduled, average and maximum values. These are valuation figures and are not guaranteed payments.
| Disease | Scheduled Value | Average Value | Maximum Value |
|---|---|---|---|
| Mesothelioma — Level VIII | $155,000 | $225,000 | $450,000 |
| Lung Cancer 1 — Level VII | $45,000 | $55,000 | $100,000 |
| Lung Cancer 2 — Level VI | Individual Review only | $15,000 | $35,000 |
| Other Cancer — Level V | $15,000 | $18,000 | $35,000 |
| Severe Asbestosis — Level IV | $30,000 | $35,000 | $50,000 |
| Asbestosis/Pleural Disease — Level III | $8,300 | Not listed | Not listed |
| Asbestosis/Pleural Disease — Level II | $2,625 | Not listed | Not listed |
| Other Asbestos Disease — Level I | $150 cash discount payment | Not listed | Not listed |
The TDP permits periodic adjustments to scheduled values for inflation and other permitted reasons. Claimants should therefore use the current trust materials when a claim is actually filed or reviewed.
5% Payment Rate and Examples
The trust’s December 1, 2022 official notice records a proposed decrease from 7.4% and states that claims first eligible for payment after November 22, 2022 would be paid at 5% while the proposed decrease was being resolved. Because the official resource page reviewed for this update continues to publish that notice without a newer surfaced payment-rate notice, 5% is the rate used for the illustrations below.
| Mathematical Example | Scheduled Value | 5% Illustration |
|---|---|---|
| Mesothelioma | $155,000 | $7,750 |
| Lung Cancer 1 | $45,000 | $2,250 |
| Other Cancer | $15,000 | $750 |
These are mathematical illustrations only. They do not guarantee eligibility, liquidation value or payment. The TDP also contains special rules for Disease Level I and for changes or proposed changes in the payment percentage.
Need help reviewing GAF or G-I Holdings exposure records? Call 800.291.0963. Live chat available 24/7, 365 days a year. Submit Your Case.
Exposure and Medical Requirements
The official G-I filing instructions require a claimant to document G-I Exposure and provide the occupation and industry in which the injured person worked when that exposure occurred. A fully completed claim form signed by the injured person under penalty of perjury may serve as exposure evidence for the applicable TDP provision.
For Expedited Review, several disease levels require additional Significant Occupational Exposure. The TDP lists specific medical and exposure criteria. For example, mesothelioma requires a qualifying diagnosis and G-I Exposure. Lung Cancer 1 requires a primary lung-cancer diagnosis, specified underlying asbestos-related nonmalignant disease, six months of G-I Exposure before December 31, 1982, Significant Occupational Exposure and supporting medical documentation connecting asbestos exposure to the lung cancer.
The official trust resource page also provides a GAF/Ruberoid asbestos-containing products document and approved-site lists that may assist exposure research. Medical evidence and exposure evidence remain separate requirements.
Confirmed Primary Sources for Trust Facts
Trust facts on this page are based on official trust documents, federal court records and SEC filings rather than law-firm or lead-generation websites.
- G-I Holdings, Inc. Second Amended Trust Distribution Procedures: disease levels, scheduled values, average and maximum values, exposure criteria, review methods and payment rules.
- G-I Holdings official December 1, 2022 payment notice: payment-percentage history and 5% treatment for claims first eligible after November 22, 2022 while the proposed decrease was being resolved.
- G-I official filing instructions: G-I Exposure, Significant Occupational Exposure and claim-payment procedures.
- G-I official resource page: current trust documents, approved-site lists, GAF/Ruberoid product information and filing resources.
- Federal confirmation record: Section 524(g) trust structure, $215 million cash contribution and $560 million Trust Note.
- SEC filings: G-I Holdings’ status as successor to GAF Corporation by merger and bankruptcy background.
Not published without acceptable current confirmation: a 2026 trust asset balance, 2025 or 2026 annual claims-paid total, current cumulative claims paid or current lifetime dollars paid. Historical financial figures are not presented as current balances.
Other Trust and Legal Options
GAF/G-I exposure may have occurred alongside asbestos products associated with other manufacturers, insulation companies and construction-material suppliers. Each trust requires its own medical and exposure evidence, and qualification for the G-I Trust does not automatically establish another claim or lawsuit.
Related Asbestos Trust Fund Resources
Manufacturer Trust Information
Filing and Eligibility
- Step-by-Step Guide to Filing an Asbestos Trust Claim
- Asbestos Trust Fund Requirements
- How to Avoid Trust Fund Filing Errors
Payments and Legal Strategy
GAF Asbestos Trust FAQs
What trust handles GAF asbestos claims?
Covered asbestos personal-injury claims associated with GAF Corporation are handled through the G-I Holdings, Inc. Asbestos Personal Injury Settlement Trust. G-I Holdings is the successor to GAF Corporation by merger.
What payment rate is supported by the current official G-I resource materials?
The official December 1, 2022 notice states that claims first eligible for payment after November 22, 2022 would be paid at 5% while the proposed decrease was being resolved. The official resource page reviewed for this update continues to publish that notice.
What is the G-I mesothelioma scheduled value?
The official TDP lists $155,000 scheduled, $225,000 average and $450,000 maximum for Level VIII mesothelioma. These are valuation figures, not guaranteed payments.
What is the Lung Cancer 1 scheduled value?
The official TDP lists $45,000 scheduled, $55,000 average and $100,000 maximum for Level VII Lung Cancer 1.
What is 5% of the $155,000 mesothelioma scheduled value?
The mathematical result is $7,750. This is an illustration only and does not guarantee that a claimant qualifies or will receive that amount.
What exposure evidence does the G-I Trust require?
The filing instructions require G-I Exposure evidence and occupation and industry information. Several disease levels also require Significant Occupational Exposure and additional medical evidence.
How was the G-I asbestos trust funded?
The federal confirmation record describes a $215 million cash contribution and a 10-year $560 million Trust Note as major plan funding components. These are historical funding commitments, not a current trust balance.
Does the trust provide GAF product and approved-site information?
Yes. The official G-I resource page includes GAF/Ruberoid asbestos-containing product information and approved-site lists to assist claim and exposure research.
Get Help Reviewing a GAF Asbestos Trust Claim
If you or a family member has been diagnosed with mesothelioma, asbestos-related lung cancer or another asbestos-related disease and you are investigating GAF or G-I Holdings exposure, a review can help organize potentially relevant medical, employment, product and worksite evidence.
Call 800.291.0963 to discuss the work history, products, worksites and years of possible exposure you remember. Live chat is available 24/7, 365 days a year. Submit Your Case using the form below.
Prior asbestos exposure does not automatically establish eligibility for a trust claim or lawsuit. Trust availability, eligibility, filing requirements, payment percentages and legal options depend on current procedures, evidence and individual circumstances. Compensation is not guaranteed.
⚕️ Legal & Medical Information Disclaimer
This page provides general educational information and is not medical or legal advice. The information does not establish asbestos exposure, diagnosis, causation, liability, claim eligibility or compensation. Medical concerns should be discussed with a qualified healthcare professional, and legal questions should be reviewed with a qualified attorney.